Watch now

Exhibitor Showcase

As an extra meeting place between exhibitors, visitors & press located on the show floor, speakers have 45 minutes to educate the industry about their products, services, new launches, innovations and news. These sessions are free to attend to all visitors to Hi Korea and co-located events.

  • Dates: 22 - 24 August, 2017
  • Venue: Exhibitor showcase room in the exhibion hall

2016 Exhibitor Showcase Schedule

Date Time Title Company Relevant events
8.23
(Tue)
14:00 ~
14:45
Accelerated CMC Approaches for Therapeutic Antibody Development KBI Biopharma
(Thomas Jung, M.S.)
15:00 ~ 15:45 Cold Chain Management for Pharmaceutical, medical device Bollore Logistics
(Emmanuel PETREQUIN)
(James Namgoong)
8.24 (Wed) 10:15 ~
11:00
New regulation for health food claims in Japan Health Industry News
(Junichi Makino)
11:15 ~
12:00
Funtional and health ingredients market in Japan Health Industry News
(Junichi Makino)
14:00 ~
15:45
Applications of physical analyses, such as viscosity, thermal stability, size distribution, chemical spectroscopy and sub-visible particle (SVP) Malvern Korea
(Kohei Shiba)
8.25 (Thu) 11:15 ~
12:00
Probiotics-STAR: Proprietary enteric coating technology Bision Biochem
(Audrey Dupuy)

2016 Exhibitor Showcase Agenda & Speakers

<Special Seminar>
Junichi Makino
Health Industry News, Japan
10:15 - 12:00, Wednesday, August 24
- New regulation for health food claims in Japan
- Funtional and health ingredients market in Japan
Japan's New Regulations for Health Food Claims – an Explanation

In April 2015, the Consumer Affairs Agency of the Japanese government implemented new rules for the labeling of health foods. The new kinosei hyoji shokuhin rules are designed to be a middle road between two existing food labels: tokuho, short for tokutei hokenyo shokuhin, or food with specified health uses, and eiyo kino shokuhin, or foods boasting nutrient functions.

Tokuho was launched in 1991 and allows manufacturers to make health claims on their products if the government judges that there is enough scientific evidence of their benefits and safety. Eiyo kino shokuhin, is a label that manufacturers can use so long as the products contain designated vitamins and minerals. The label can be used without reporting to the authorities.

The new labels are similar to tokuho, in that manufacturers can make specific health claims, but unlike tokuho the government does not review or guarantee the safety and efficacy of the individual products.

Trends and Developments in Japan Health Ingredients Market

Japan is home to the third-largest health food market in the world. The category that has the highest market share is for intestinal regulation products. The second largest category is for products aimed at preventing lifestyle-related diseases, followed by products intended to restore a person's health or strength.

The market is dynamic with a constant flow of new ingredients and products being developed and commercialized. This presentation will highlight some of the recent trends and developments in the market and highlight the opportunities for companies wishing to enter the Japan market.
Thomas Jung, M.S.
Vice President, Business Development, KBI Biopharma, USA
14:00 - 14:45, Tuesday, August 23
Accelerated CMC Approaches for Therapeutic Antibody Development
Accelerating the development and delivery of innovative and biosimilar antibodies to patients enhances quality of care and quality of life.  Shortening development times also helps biotech companies efficiently deploy capital while providing their investors with a faster return on investment.  This presentation outlines specific areas where KBI significantly reduces development timelines to enable faster progression into and through clinical trials for therapeutic antibodies.

Emmanuel PETREQUIN
Head Regional Accounts, Asia Pacific at Bollore Logistics Singapore, Singapore
15:00 - 15:45, Tuesday, August 23
Cold Chain Management for Pharmaceutical, medical device
Bollore logistics, headquartered in Paris FRANCE, is a global leader in Int'l Transport & Logistics. We are operating in 102 countries with 21,000 employees. The company has enriched its expertise to become a tier-one supply chain partner and one of the Top 10 logistics company in the world with its integrated logistics network and knowledge. In line with strong corporate QHSE policy and culture, Bollore Logistics Korea has invested to Healthcare logistics in cooperation with the expertise in HQ and Regional Healthcare Management. Our investment result in CEIV Pharma Certificate & opening KGSP warehouse in Osan.

James Namgoong
Healthcare Business Development Manager, Bollore Logistics Korea
15:00 - 15:45, Tuesday, August 23
Cold Chain Management for Pharmaceutical, medical device
Bollore logistics, headquartered in Paris FRANCE, is a global leader in Int'l Transport & Logistics. We are operating in 102 countries with 21,000 employees. The company has enriched its expertise to become a tier-one supply chain partner and one of the Top 10 logistics company in the world with its integrated logistics network and knowledge. In line with strong corporate QHSE policy and culture, Bollore Logistics Korea has invested to Healthcare logistics in cooperation with the expertise in HQ and Regional Healthcare Management. Our investment result in CEIV Pharma Certificate & opening KGSP warehouse in Osan.

Kohei Shiba
Asia Pacific Manager, Malvern Japan, Japan
14:00 - 15:45, Wednesday, August 24
Applications of physical analyses, such as viscosity, thermal stability, size distribution, chemical spectroscopy and sub-visible particle (SVP)
Therapeutic protein development requires some physical analyses because a protein has each conformation in various formulations. We will here present some applications of physical analyses, such as viscosity, thermal stability, size distribution, chemical spectroscopy and sub-visible particle (SVP) detection with Malvern products. We also trace them on the development work flow for biopharmaceuticals in order to show total solution.

Audrey Dupuy
Technical Support Manager, Lallemand Health Solutions, USA
11:15 - 12:00, Thursday, August 25
Probiotics-STAR: Proprietary enteric coating technology
Lallemand Health Solutions (LHS) is pioneer in probiotics for 80 years through expertise and continuing R&D work  to supply the best Probiotic strains and products. Thanks to STAR® 3-level protection technology, Lallemand Health Solutions ensures the optimal delivery of live probiotics in the gut. STAR® can be applied to any custom blends of Rosell, Lafti and Harmonium strains formulated in capsules, and LHS also possesses strong expertise in the selection, development, production, and formulations (specialized, customized blends for customers) that support human health and well-being.

For more inquiries regarding Free Seminar, please contact Evelyn Kang (82-2-6715-5400, Evelyn.Kang@ubm.com).

Go to Conference